Literature DB >> 31504815

EGFR amplification status for clinical trial inclusion: where do we draw the line?

Annette M Molinaro1, Joanna J Phillips2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31504815      PMCID： PMC6784265          DOI： 10.1093/neuonc/noz146

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  11 in total

Review 1.  Statistical considerations on prognostic models for glioma.

Authors:  Annette M Molinaro; Margaret R Wrensch; Robert B Jenkins; Jeanette E Eckel-Passow
Journal:  Neuro Oncol       Date:  2015-12-08       Impact factor: 12.300

2.  The somatic genomic landscape of glioblastoma.

Authors:  Cameron W Brennan; Roel G W Verhaak; Aaron McKenna; Benito Campos; Houtan Noushmehr; Sofie R Salama; Siyuan Zheng; Debyani Chakravarty; J Zachary Sanborn; Samuel H Berman; Rameen Beroukhim; Brady Bernard; Chang-Jiun Wu; Giannicola Genovese; Ilya Shmulevich; Jill Barnholtz-Sloan; Lihua Zou; Rahulsimham Vegesna; Sachet A Shukla; Giovanni Ciriello; W K Yung; Wei Zhang; Carrie Sougnez; Tom Mikkelsen; Kenneth Aldape; Darell D Bigner; Erwin G Van Meir; Michael Prados; Andrew Sloan; Keith L Black; Jennifer Eschbacher; Gaetano Finocchiaro; William Friedman; David W Andrews; Abhijit Guha; Mary Iacocca; Brian P O'Neill; Greg Foltz; Jerome Myers; Daniel J Weisenberger; Robert Penny; Raju Kucherlapati; Charles M Perou; D Neil Hayes; Richard Gibbs; Marco Marra; Gordon B Mills; Eric Lander; Paul Spellman; Richard Wilson; Chris Sander; John Weinstein; Matthew Meyerson; Stacey Gabriel; Peter W Laird; David Haussler; Gad Getz; Lynda Chin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

Review 3.  Molecular pathologic diagnosis of epidermal growth factor receptor.

Authors:  Cecile L Maire; Keith L Ligon
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

4.  Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.

Authors:  Matija Snuderl; Ladan Fazlollahi; Long P Le; Mai Nitta; Boryana H Zhelyazkova; Christian J Davidson; Sara Akhavanfard; Daniel P Cahill; Kenneth D Aldape; Rebecca A Betensky; David N Louis; A John Iafrate
Journal:  Cancer Cell       Date:  2011-12-01       Impact factor: 31.743

5.  Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBM.

Authors:  Andrew McKinney; Olle R Lindberg; Jane R Engler; Katharine Y Chen; Anupam Kumar; Henry Gong; Kan V Lu; Erin F Simonds; Timothy F Cloughesy; Linda M Liau; Michael Prados; Andrew W Bollen; Mitchel S Berger; Joseph T C Shieh; C David James; Theodore P Nicolaides; William H Yong; Albert Lai; Monika E Hegi; William A Weiss; Joanna J Phillips
Journal:  Mol Cancer Ther       Date:  2019-07-03       Impact factor: 6.261

Review 6.  Extrachromosomal oncogene amplification in tumour pathogenesis and evolution.

Authors:  Roel G W Verhaak; Vineet Bafna; Paul S Mischel
Journal:  Nat Rev Cancer       Date:  2019-05       Impact factor: 60.716

Review 7.  Epidermal growth factor receptor: a re-emerging target in glioblastoma.

Authors:  Monika E Hegi; Premnath Rajakannu; Michael Weller
Journal:  Curr Opin Neurol       Date:  2012-12       Impact factor: 5.710

8.  EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

Authors:  Joshua M Francis; Cheng-Zhong Zhang; Cecile L Maire; Joonil Jung; Veronica E Manzo; Viktor A Adalsteinsson; Heather Homer; Sam Haidar; Brendan Blumenstiel; Chandra Sekhar Pedamallu; Azra H Ligon; J Christopher Love; Matthew Meyerson; Keith L Ligon
Journal:  Cancer Discov       Date:  2014-06-03       Impact factor: 39.397

9.  cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".

Authors:  Daniel J Brat; Kenneth Aldape; Howard Colman; Eric C Holland; David N Louis; Robert B Jenkins; B K Kleinschmidt-DeMasters; Arie Perry; Guido Reifenberger; Roger Stupp; Andreas von Deimling; Michael Weller
Journal:  Acta Neuropathol       Date:  2018-09-26       Impact factor: 17.088

10.  Defining EGFR amplification status for clinical trial inclusion.

Authors:  Pim J French; Marica Eoli; Juan Manuel Sepulveda; Iris de Heer; Johan M Kros; Annemiek Walenkamp; Jean-Sebastien Frenel; Enrico Franceschi; Paul M Clement; Michael Weller; Peter Ansell; Jim Looman; Earle Bain; Marie Morfouace; Thierry Gorlia; Martin van den Bent
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.